Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of oral recombinant oxalate decarboxylase powder in secondary hyperoxaluria
CTR20230413Phase 2Completed
- Sponsor
- Comfort Biopharma
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant oxalate decarboxylase in secondary hyperoxaluria, sponsored by Comfort Biopharma. Started May 2023; status: completed.
02
Drugs
recombinant oxalate decarboxylase
03
Conditions
secondary hyperoxaluria
Beyond the preview
Go deeper on CTR20230413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230413.